Literature DB >> 2955896

Percutaneous transluminal angioplasty of the distal abdominal aorta and its bifurcation.

B Morag, Z Rubinstein, A Kessler, J Schneiderman, M Levinkopf, A Bass.   

Abstract

Percutaneous transluminal angioplasty (PTA) of stenotic lesions in the distal abdominal aorta and its bifurcation was performed in 14 patients, 6 of whom were women. The stenotic segment in the aorta or aortic bifurcation was usually the only significant lesion. The double-balloon technique was used in 12 patients via bilateral femoral artery catheterizations. In 2 other patients with aortic lesions, a single large balloon sufficed. Good results were achieved in all but 1 patient, with minor complications occurring in 3 instances. The follow-up period varied from 6 months to 5 years. We believe that PTA is the procedure of choice in treating localized lesions of the distal abdominal aorta and its bifurcation, especially when distal vessels are relatively uninvolved.

Entities:  

Mesh:

Year:  1987        PMID: 2955896     DOI: 10.1007/bf02577986

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  15 in total

1.  Aortic rupture: a complication of transluminal angioplasty.

Authors:  T Berger; R Sörensen; J Konrad
Journal:  AJR Am J Roentgenol       Date:  1986-02       Impact factor: 3.959

Review 2.  Percutaneous transluminal angioplasty. The radiologist's contribution to the treatment of vascular disease.

Authors:  A R Wilson; J C Fuchs
Journal:  Surg Clin North Am       Date:  1984-02       Impact factor: 2.741

3.  Transluminal angioplasty of the abdominal aorta.

Authors:  D Heeney; J Bookstein; E Daniels; M Warmath; J Horn; W Rowley
Journal:  Radiology       Date:  1983-07       Impact factor: 11.105

4.  Percutaneous transluminal abdominal aortic angioplasty.

Authors:  J H Grollman; M Del Vicario; A K Mittal
Journal:  AJR Am J Roentgenol       Date:  1980-05       Impact factor: 3.959

Review 5.  Impotence in vascular disease: relationship to vascular surgery.

Authors:  R G Depalma
Journal:  Br J Surg       Date:  1982-06       Impact factor: 6.939

6.  Nonsurgical aortoplasty in Leriche syndrome.

Authors:  G Velasquez; W Castaneda-Zuniga; A Formanek; C Zollikofer; A Barreto; D Nicoloff; K Amplatz; A Sullivan
Journal:  Radiology       Date:  1980-02       Impact factor: 11.105

7.  Segmental aortic occlusion: An unusual lesion found in menopausal women.

Authors:  M J Costantino; R B Smith; G D Perdue
Journal:  Arch Surg       Date:  1979-03

8.  Atherosclerosis and the hypoplastic aortoiliac system.

Authors:  D A DeLaurentis; P Friedman; C C Wolferth; A Wilson; D Naide
Journal:  Surgery       Date:  1978-01       Impact factor: 3.982

9.  Percutaneous transluminal angioplasty in the region of the aortic bifurcation. The two-balloon technique with results and long-term follow-up study.

Authors:  C J Tegtmeyer; C D Kellum; I L Kron; R M Mentzer
Journal:  Radiology       Date:  1985-12       Impact factor: 11.105

10.  Aortoiliac operations and sexual dysfunction.

Authors:  J R Miles; D G Miles; G Johnson
Journal:  Arch Surg       Date:  1982-09
View more
  4 in total

1.  Stent placement for failed angioplasty of aortic stenoses: report of two cases.

Authors:  D Vorwerk; R W Günther; K Bohndorf; P Keulers
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Sep-Oct       Impact factor: 2.740

2.  Stenting for abdominal aortic occlusive disease. Long-term results.

Authors:  R Martinez; J Rodriguez-Lopez; E B Diethrich
Journal:  Tex Heart Inst J       Date:  1997

3.  Infrarenal aortic stents: initial clinical experience and angiographic follow-up.

Authors:  A L Long; J C Gaux; A C Raynaud; J M Faintuch; J Y Pagny; P Lacombe; J N Fiessinger; J Y Relland; B M Beyssen
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Jul-Aug       Impact factor: 2.740

4.  Percutaneous transluminal aortic angioplasty: early and late results.

Authors:  B Morag; A Garniek; A Bass; J Schneiderman; R Walden; Z J Rubinstein
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Jan-Feb       Impact factor: 2.740

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.